Hypoglycemia

Williams Textbook of Endocrinology, Twelfth Edition

Volumn , Issue , 2011, Pages 1552-1577

  Cryer, Philip E ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85170157560     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0324-5.00034-1     Document Type: Chapter

References (236)

1. DD Clark and L Sokoloff (1994) Circulation and energy metabolism of the brain. G Siegel, B Agranoff, RW Albers, P Molinoff,(Eds) Basic Neurochemistry: Molecular, Cellular and Medical Aspects 5th ed New York: Raven Press 645-680.
2. PE Cryer, L Axelrod, AB Grossman, et al. (2009) Evaluation and management of adult hypoglycemic disorders: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 94 709-728.
3. PE Cryer (2009) Hypoglycemia in Diabetes: Pathophysiology, Prevalence and Prevention. Alexandria, VA: American Diabetes Association
4. PE Cryer (2001) The prevention and correction of hypoglycemia. LS Jefferson, AD Cherrington,(Eds) Handbook of Physiology. Section 7: The Endocrine System. Volume II: The Endocrine Pancreas and Regulation of Metabolism New York: Oxford University Press 1057-1092.
5. PE Cryer (2007) Hypoglycemia, functional brain failure and brain death. J Clin Invest 117 868-870.
6. G Boden (2004) Gluconeogenesis and glycogenolysis in health and diabetes. J Investig Med 52 375-378.
7. M Stumvoll, U Chintalapudi, G Perriello, et al. (1995) Uptake and release of glucose by the human kidney. J Clin Invest 96 2528-2533.
8. HJ Woerle, C Meyer, EM Popa, et al. (2003) Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 diabetes: further evidence for hepatorenal reciprocity. Diabetes 52 1386-1392.
9. NS Schwartz, WE Clutter, SD Shah, et al. (1987) Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79 777-781.
10. A Mitrakou, C Ryan, T Veneman, et al. (1991) Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol Endocrinol Metab 260 E67-E74.
11. C Fanelli, S Pampanelli, L Epifano, et al. (1994) Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 37 797-807.
12. DA Towler, CE Havlin, S Craft, et al. (1993) Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 42 1791-1798.
13. MA DeRosa and PE Cryer (2004) Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am J Physiol Endocrinol Metab 287 E32-E41.
14. B Schultes, KM Oltmanns, W Kern, et al. (2003) Modulation of hunger by plasma glucose and metformin. J Clin Endocrinol Metab 88 1133-1141.
15. B Raju and PE Cryer (2005) Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes. Diabetes 54 757-764.
16. GJ Taborsky Jr, B Ahrén and PJ Havel (1998) Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes. Diabetes 47 995-1005.
17. MA Berk, WE Clutter, D Skor, et al. (1985) Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. J Clin Invest 75 1842-1851.
18. A Mitrakou, C Fanelli, T Veneman, et al. (1993) Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med 329 834-839.
19. SA Amiel, RS Sherwin, DC Simonson, et al. (1988) Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37 901-907.
20. PJ Boyle, NS Schwartz, SD Shah, et al. (1988) Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 318 1487-1492.
21. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 977-986.
22. P Reichard and M Pihl (1994) Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes 43 313-317.
23. LA Donnelly, AD Morris, BM Frier, et al. (2005) Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med 22 749-755.
24. U.K. Hypoglycaemia Study Group (2007) Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50 1140-1147.
25. The Diabetes Control and Complications Trial Research Group (1997) Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46 271-286.
26. Y Ohkubo, H Kishikawa, E Araki, et al. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28 103-117.
27. C Abraira, JA Colwell, FQ Nuttall, et al. (1995) Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Diabetes Care 18 1113-1123.
28. H Yki-Järvinen, L Ryysy, K Nikkilä, et al. (1999) Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 130 389-396.
29. CD Saudek, WC Duckworth, A Giobbie-Hurder, et al. (1996) Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. JAMA 276 1322-1327.
30. GH Murata, WC Duckworth, JH Shah, et al. (2005) Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1662 episodes. J Diabetes Complications 19 10-17.
31. United Kingdom Prospective Diabetes Study Group (1998) United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med 128 165-175.
32. DA Hepburn, KM MacLeod, AC Pell, et al. (1993) Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med 10 231-237.
33. A Holstein, A Plaschke and EH Egberts (2003) Clinical characterisation of severe hypoglycaemia: a prospective population-based study. Exp Clin Endocrinol Diabetes 111 364-369.
34. GP Leese, J Wang, J Broomhall, et al., DARTS/MEMO Collaboration (2003) Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 26 1176-1180.
35. AD Wright, CA Cull, KM Macleod, et al. (2006) Hypoglycemia in type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis. UKPDS73. J Diabetes Complications 20 395-401. for the UKPDS Group
36. WL Clarke, DJ Cox, LA Gonder-Frederick, et al. (1995) Reduced awareness of hypoglycemia in adults with IDDM: a prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 18 517-522.
37. S Pramming, B Thorsteinsson, I Bendtson, et al. (1991) Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 8 217-222.
38. U Pedersen-Bjergaard, S Pramming and B Thorsteinsson (2003) Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev 19 232-240.
39. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group (2007) Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 356 1842-1852.
40. T Hershey, DC Perantie, SL Warren, et al. (2005) Frequency and timing of severe hypoglycemia affects spatial memory in children with type 1 diabetes. Diabetes Care 28 2372-2377.
41. DC Perantie, J Wu, JM Koller, et al. (2007) Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 30 2331-2337.
42. AM Jacobson (1996) The psychological care of patients with insulin-dependent diabetes mellitus. N Engl J Med 334 1249-1253.
43. T Deckert, JE Poulsen and M Larsen (1978) Prognosis of diabetics with diabetes onset before the age of thirty-one. I: Survival, causes of death, and complications. Diabetologia 14 363-370.
44. WM Tunbridge (1981) Factors contributing to deaths of diabetics under fifty years of age. Lancet 2 569-572.
45. SP Laing, AJ Swerdlow, SD Slater, et al. (1999) The British Diabetic Association Cohort Study. I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 16 459-465.
46. RG Feltbower, HJ Bodansky, CC Patterson, et al. (2008) Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes: results from the Yorkshire Register of diabetes in children and young adults. Diabetes Care 31 922-926.
47. T Skrivarhaug, HJ Bangstad, LC Stene, et al. (2006) Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 49 298-305.
48. JE Gerich (1989) Oral hypoglycemic agents. N Engl J Med 321 1231-1245.
49. A Holstein and EH Egberts (2003) Risk of hypoglycaemia with oral antidiabetic agents in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 111 405-414.
50. Action to Control Cardiovascular Risk in Diabetes Study Group (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 2545-2559.
51. RT Robinson, ND Harris, RH Ireland, et al. (2003) Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes 52 1469-1474.
52. SP Lee, ND Harris, RT Robinson, et al. (2005) Effect of atenolol on QTc interval lengthening during hypoglycaemia in type 1 diabetes. Diabetologia 48 1269-1272.
53. A Rothenbuhler, CP Bibal, S Le Fur, et al. (2008) Effects of a controlled hypoglycaemia test on QTc in adolescents with Type 1 diabetes. Diabet Med 25 1483-1485.
54. NP Murphy, ME Ford-Adams, KK Ong, et al. (2004) Prolonged cardiac repolarisation during spontaneous nocturnal hypoglycaemia in children and adolescents with type 1 diabetes. Diabetologia 47 1940-1947.
55. GV Gill, A Woodward, IF Casson, et al. (2009) Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes: the “dead in bed” syndrome revisited. Diabetologia 52 42-45.
56. DJ Ewing and JM Neilson (1990) QT interval length and diabetic autonomic neuropathy. Diabet Med 7 23-26.
57. GK Adler, I Bonyhay, H Failing, et al. (2009) Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control. Diabetes 58 360-366.
58. American Diabetes Association Workgroup on Hypoglycemia (2005) Defining and reporting hypoglycemia in diabetes. Diabetes Care 28 1245-1249.
59. DJ Cox, L Gonder-Frederick, L Ritterband, et al. (2007) Prediction of severe hypoglycemia. Diabetes Care 30 1370-1373.
60. SN Davis, C Shavers, R Mosqueda-Garcia, et al. (1997) Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 46 1328-1335.
61. PE Cryer (2009) Preventing hypoglycaemia: what is the appropriate glucose alert value? Diabetologia 52 35-37.
62. SE Dagogo-Jack, S Craft and PE Cryer (1993) Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus: recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 91 819-828.
63. SA Segel, DS Paramore and PE Cryer (2002) Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 51 724-733.
64. NH White, DA Skor, PE Cryer, et al. (1983) Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308 485-491.
65. GB Bolli, P De Feo, S De Cosmo, et al. (1984) A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes 33 732-737.
66. J Geddes, JE Schopman, NN Zammitt, et al. (2008) Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabet Med 25 501-504.
67. SR Heller and PE Cryer (1991) Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 40 223-226.
68. P Galassetti, S Mann, D Tate, et al. (2001) Effects of antecedent prolonged exercise on subsequent counterregulatory responses to hypoglycemia. Am J Physiol Endocrinol Metab 280 E908-E917.
69. DA Sandoval, DL Guy, MA Richardson, et al. (2004) Effects of low and moderate antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes. Diabetes 53 1798-1806.
70. AC Ertl and SN Davis (2004) Evidence for a vicious cycle of exercise and hypoglycemia in type 1 diabetes mellitus. Diabetes Metab Res Rev 20 124-130.
71. TW Jones, P Porter, RS Sherwin, et al. (1998) Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 338 1657-1662.
72. S Banarer and PE Cryer (2003) Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes 52 1195-1203.
73. B Schultes, K Jauch-Chara, S Gais, et al. (2007) Defective awakening response to nocturnal hypoglycemia in patients with type 1 diabetes mellitus. PLoS Med 4 e69.
74. I Berlin, A Grimaldi, C Payan, et al. (1987) Hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients. Diabetes Care 10 742-747.
75. A Fritsche, N Stefan, H Häring, et al. (2001) Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes. Ann Intern Med 134 729-736.
76. BE De Galan, P De Mol, L Wennekes, et al. (2006) Preserved sensitivity to beta2-adrenergic receptor agonists in patients with type 1 diabetes mellitus and hypoglycemia unawareness. J Clin Endocrinol Metab 91 2878-2881.
77. P Bottini, E Boschetti, S Pampanelli, et al. (1997) Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. Diabetes 46 814-823.
78. C Meyer, R Grossmann, A Mitrakou, et al. (1998) Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients. Diabetes Care 21 1960-1966.
79. CG Fanelli, DS Paramore, T Hershey, et al. (1998) Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes 47 1920-1927.
80. F Ovalle, CG Fanelli, DS Paramore, et al. (1998) Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. Diabetes 47 1472-1479.
81. CG Fanelli, L Epifano, AM Rambotti, et al. (1993) Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42 1683-1689.
82. I Cranston, J Lomas, A Maran, et al. (1994) Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344 283-287.
83. C Fanelli, S Pampanelli, L Epifano, et al. (1994) Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 37 1265-1276.
84. S Dagogo-Jack, C Rattarasarn and PE Cryer (1994) Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 43 1426-1434.
85. MJ MacDonald (1987) Postexercise late-onset hypoglycemia in insulin-dependent diabetic patients. Diabetes Care 10 584-588.
86. MJ Tansey, E Tsalikian, RW Beck, et al. (2006) The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care 29 20-25. for The Diabetes Research in Children Network (DirecNet) Study Group
87. P Diem, JB Redmon, M Abid, et al. (1990) Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J Clin Invest 86 2008-2013.
88. SM Sherck, M Shiota, J Saccomando, et al. (2001) Pancreatic response to mild non-insulin-induced hypoglycemia does not involve extrinsic neural input. Diabetes 50 2487-2496.
89. PE Cryer (2005) Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 54 3592-3601.
90. RS Sherwin (2008) Bringing light to the dark side of insulin: a journey across the blood-brain barrier. Diabetes 57 2259-2268.
91. D Teves, TO Videen, PE Cryer, et al. (2004) Activation of human medial prefrontal cortex during autonomic responses to hypoglycemia. Proc Natl Acad Sci U S A 101 6217-6221.
92. AM Arbelaez, WJ Powers, TO Videen, et al. (2008) Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure. Diabetes 57 470-475.
93. PE Cryer, SN Davis and H Shamoon (2003) Hypoglycemia in diabetes. Diabetes Care 26 1902-1912.
94. The DCCT Research Group (1991) Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 90 450-459.
95. M Fukuda, A Tanaka, Y Tahara, et al. (1988) Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control. Diabetes 37 81-88.
96. TME Davis, SGA Brown, IG Jacobs, et al. (2010) Determinants of severe hypoglycemia complicating type 2 diabetes: The Fremantle Diabetes Study. J Clin Endocrinol Metab. 95 2240-2247.
97. I Mühlhauser, H Overmann, R Bender, et al. (1998) Risk factors of severe hypoglycaemia in adult patients with Type I diabetes: a prospective population based study. Diabetologia 41 1274-1282.
98. C Allen, T LeCaire, M Palta, et al. (2001) Risk factors for frequent and severe hypoglycemia in type 1 diabetes. Diabetes Care 24 1878-1881.
99. MW Steffes, S Sibley, M Jackson, et al. (2003) Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 26 832-836.
100. HJ Lüddeke, S Sreenan, S Aczel, et al. (2007) PREDICTIVE—a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort. Diabetes Obes Metab 9 428-434.
101. M Egger, G Davey Smith, C Stettler, et al. (1997) Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med 14 919-928.
102. S Davis and MD Alonso (2004) Hypoglycemia as a barrier to glycemic control. J Diabetes Complications 18 60-68.
103. BE de Galan, BJ Schouwenberg, CJ Tack, et al. (2006) Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes. Neth J Med 64 269-279.
104. PJ Boyle and J Zrebiec (2007) Management of diabetes-related hypoglycemia. South Med J 100 183-194.
105. P Rossetti, F Porcellati, GB Bolli, et al. (2008) Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs. Diabetes Care 31(suppl 2), S113-S120.
106. SR Heller (2008) Minimizing hypoglycemia while maintaining glycemic control in diabetes. Diabetes 57 3177-3183.
107. LA Gonder-Frederick, CD Fisher, LM Ritterband, et al. (2006) Predictors of fear of hypoglycemia in adolescents with type 1 diabetes and their parents. Pediatr Diabetes 7 215-222.
108. S Nordfeldt and J Ludvigsson (2005) Fear and other disturbances of severe hypoglycaemia in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 18 83-91.
109. DJ Cox, B Kovatchev, D Koev, et al. (2004) Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus. Int J Behav Med 11 212-228.
110. BP Kovatchev, DJ Cox, LA Gonder-Frederick, et al. (1998) Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care 21 1870-1875.
111. BP Kovatchev, DJ Cox, A Kumar, et al. (2003) Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. Diabetes Technol Ther 5 817-828.
112. DJ Cox, L Gonder-Frederick, L Ritterband, et al. (2007) Prediction of severe hypoglycemia. Diabetes Care 30 1370-1373.
113. R Hovorka (2006) Continuous glucose monitoring and closed-loop systems. Diabet Med 23 1-12.
114. D Deiss, R Hartmann, J Schmidt, et al. (2006) Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes 114 63-67.
115. DM Wilson, RW Beck, WV Tamborlane, et al., DirecNet Study Group (2007) The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care 30 59-64.
116. B Buckingham, K Caswell and DM Wilson (2007) Real-time continuous glucose monitoring. Curr Opin Endocrinol Diabetes Obes 14 288-295.
117. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008) Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 359 1464-1476.
118. S Bolen, L Feldman, J Vassy, et al. (2007) Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 147 386-399.
119. United Kingdom Prospective Diabetes Study Group (1995) Overview of 6 years’ therapy of type II diabetes: a progressive disease. UKPDS 16. Diabetes 44 1249-1258.
120. J de Heer and JJ Holst (2007) Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1. Diabetes 56 438-443.
121. A Holstein and EH Egberts (2003) Risk of hypoglycaemia with oral antidiabetic agents in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 111 405-414.
122. AS Gangji, T Cukierman, HC Gerstein, et al. (2007) A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin. Diabetes Care 30 389-394.
123. IB Hirsch (2005) Insulin analogues. N Engl J Med 352 174-183.
124. Horvath K, Jeitler K, Berghold A, et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 2007;(2):CD005613.
125. SC Gough (2007) A review of human and analogue insulin trials. Diabetes Res Clin Pract 77 1-15.
126. MM Fatourechi, YC Kudva, MH Murad, et al. (2009) Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab 94 729-740.
127. A Mukhopadhyay, T Farrell, RB Fraser, et al. (2007) Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 197 447-456.
128. B Raju, AM Arbelaez, SM Breckenridge, et al. (2006) Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments. J Clin Endocrinol Metab 91 2087-2092.
129. United Kingdom Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. UKPDS 33. Lancet 352 837-853.
130. United Kingdom Prospective Diabetes Study Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. UKPDS 34. Lancet 352 854-865.
131. The Diabetes Control and Complications Trial Research Group (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44 968-983.
132. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 2643-2653.
133. RR Holman, SK Paul, MA Bethel, et al. (2008) 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359 1577-1589.
134. American Diabetes Association (2008) Standards of medical care in diabetes—2008. Diabetes Care 31(suppl 1), S12-S54.
135. A Qaseem, S Vijan, V Snow, et al. (2007) Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med 147 417-422.
136. JM Lachin, S Genuth, DM Nathan, et al. (2008) DCCT/EDIC Research Group. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial—revisited. Diabetes 57 995-1001.
137. ES Huang, Q Zhang, N Gandra, et al. (2008) The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med 149 11-19.
138. AC MacCuish (1993) Treatment of hypoglycemia. BM Frier, BM Fisher,(Eds) Diabetes and Hypoglycemia London: Edward Arnold 212-221.
139. BV Wiethop and PE Cryer (1993) Alanine and terbutaline in treatment of hypoglycemia in IDDM. Diabetes Care 16 1131-1136.
140. MW Haymond and B Schreiner (2001) Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes. Diabetes Care 24 643-645.
141. RA Jackson, N Peters, U Advani, et al. (1973) Forearm glucose uptake during the oral glucose tolerance test in normal subjects. Diabetes 22 442-458.
142. FJ Service (1995) Hypoglycemic disorders. N Engl J Med 332 1144-1152.
143. KF Fischer, JA Lees and JH Newman (1986) Hypoglycemia in hospitalized patients: causes and outcomes. N Engl J Med 315 1245-1250.
144. R Malouf and JC Brust (1985) Hypoglycemia: causes, neurological manifestations, and outcome. Ann Neurol 17 421-430.
145. V Marks and JD Teale (1999) Drug-induced hypoglycemia. Endocrinol Metab Clin North Am 28 555-577.
146. LY Park-Wyllie, DN Juurlink, A Kopp, et al. (2006) Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 354 1352-1361.
147. MH Murad, F Coto-Yglesias, AT Wang, et al. (2009) Drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab 94 741-745.
148. MR Cohen, SM Proulx and SY Crawford (1998) Survey of hospital systems and common serious medication errors. J Healthc Risk Manag 18 16-27.
149. P Felig, WV Brown, RA Levine, et al. (1970) Glucose homeostasis in viral hepatitis. N Engl J Med 283 1436-1440.
150. S Younus, J Soterakis, AJ Sossi, et al. (1977) Hypoglycemia secondary to metastases to the liver: a case report and review of the literature. Gastroenterology 72 334-337.
151. YS Haviv, M Sharkia and R Safadi (2000) Hypoglycemia in patients with renal failure. Ren Fail 22 219-223.
152. AJ Garber, DM Bier, PE Cryer, et al. (1974) Hypoglycemia in compensated chronic renal insufficiency: substrate limitation of gluconeogenesis. Diabetes 23 982-986.
153. EA Rutsky, HG McDaniel, DL Tharpe, et al. (1978) Spontaneous hypoglycemia in chronic renal failure. Arch Intern Med 138 1364-1368.
154. YT Chen, A Burchell (1995) Glycogen storage diseases. CR Scriver, AL Beaudet, WS Sly, et al., (Eds) The Metabolic and Molecular Bases of Inherited Disease 7th ed New York, NY: McGraw Hill 935-965.
155. R Medalle, R Webb and C Waterhouse (1971) Lactic acidosis and associated hypoglycemia. Arch Intern Med 128 273-278.
156. SI Miller, RJ Wallace Jr, DM Musher, et al. (1980) Hypoglycemia as a manifestation of sepsis. Am J Med 68 649-654.
157. SR Maitra, MM Wojnar and CH Lang (2000) Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis. Shock 13 379-385.
158. Y Sakurai, XJ Zhang and RR Wolfe (1996) TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. Am J Physiol 270 E864-E872.
159. S Metzger, S Nusair, D Planer, et al. (2004) Inhibition of hepatic gluconeogenesis and enhanced glucose uptake contribute to the development of hypoglycemia in mice bearing interleukin-1beta- secreting tumor. Endocrinology 145 5150-5156.
160. DM Hargrove, CH Lang, GJ Bagby, et al. (1989) Epinephrine-induced increase in glucose turnover is diminished during sepsis. Metabolism 38 1070-1076.
161. B Wharton (1970) Hypoglycaemia in children with kwashiorkor. Lancet 1 171-173.
162. AK Bruce, E Jacobsen, H Dossing, et al. (1995) Hypoglycaemia in spinal muscular atrophy. Lancet 346 609-610.
163. MC Ørngreen, M Zacho, A Hebert, et al. (2003) Patients with severe muscle wasting are prone to develop hypoglycemia during fasting. Neurology 61 997-1000.
164. HG Goodman, MM Grumbach and SL Kaplan (1968) Growth and growth hormone. II: A comparison of isolated growth-hormone deficiency and multiple pituitary-hormone deficiencies in 35 patients with idiopathic hypopituitary dwarfism. N Engl J Med 278 57-68.
165. MW Haymond, I Karl, VV Weldon, et al. (1976) The role of growth hormone and cortisone on glucose and gluconeogenic substrate regulation in fasted hypopituitary children. J Clin Endocrinol Metab 42 846-856.
166. JI Wolfsdorf, A Sadeghi-Nejad and B Senior (1983) Hypoketonemia and age-related fasting hypoglycemia in growth hormone deficiency. Metabolism 32 457-462.
167. RT Frizzell, PJ Campbell and AD Cherrington (1988) Gluconeogenesis and hypoglycemia. Diabetes Metab Rev 4 51-70.
168. PJ Boyle and PE Cryer (1991) Growth hormone, cortisol, or both are involved in defense against, but are not critical to recovery from, hypoglycemia. Am J Physiol 260 E395-E402.
169. RC Smallridge, DF Corrigan, AM Thomason, et al. (1980) Hypoglycemia in pregnancy: occurrence due to adrenocorticotropic hormone and growth hormone deficiency. Arch Intern Med 140 564-565.
170. P Steer, R Marnell and EE Werk Jr (1969) Clinical alcohol hypoglycemia and isolated adrenocorticotrophic hormone deficiency. Ann Intern Med 71 343-348.
171. I Fukuda, N Hizuka, Y Ishikawa, et al. (2006) Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia. Growth Horm IGF Res 16 211-216.
172. MA Nauck, M Reinecke, A Perren, et al. (2007) Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung. J Clin Endocrinol Metab 92 1600-1605.
173. WH Daughaday (2007) Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I. J Clin Endocrinol Metab 92 1616.
174. F Miraki-Moud, AB Grossman, M Besser, et al. (2005) A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia. J Clin Endocrinol Metab 90 3819-3823.
175. JM Guettier and P Gorden (2006) Hypoglycemia. Endocrinol Metab Clin North Am 35 753-766.
176. V Marks and JD Teale (1999) Hypoglycemia: factitious and felonious. Endocrinol Metab Clin North Am 28 579-601.
177. FJ Service and PJ Palumbo (1974) Factitial hypoglycemia: three cases diagnosed on the basis of insulin antibodies. Arch Intern Med 134 336-340.
178. I Giurgea, T Ulinski, G Touati, et al. (2005) Factitious hyperinsulinism leading to pancreatectomy: severe forms of Munchausen syndrome by proxy. Pediatrics 116 e145-e148.
179. PJ Manning, EA Espiner, K Yoon, et al. (2003) An unusual cause of hyperinsulinaemic hypoglycaemia syndrome. Diabet Med 20 772-776.
180. KA Placzkowski, A Vella, GB Thompson, et al. (2009) Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab 94 1069-1073.
181. FJ Service, MM McMahon, PC O’Brien, et al. (1991) Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66 711-719.
182. M Anlauf, D Wieben, A Perren, et al. (2005) Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes. Am J Surg Pathol 29 524-533.
183. G Klöppel, M Anlauf, A Raffel, et al. (2008) Adult diffuse nesidioblastosis: genetically or environmentally induced? Hum Pathol 39 3-8.
184. K Kaczirek, A Soleiman, M Schindl, et al. (2003) Nesidioblastosis in adults: a challenging cause of organic hyperinsulinism. Eur J Clin Invest 33 488-492.
185. RM Witteles, FH Straus II, SL Sugg, et al. (2001) Adult-onset nesidioblastosis causing hypoglycemia: an important clinical entity and continuing treatment dilemma. Arch Surg 136 656-663.
186. FJ Service, N Natt, GB Thompson, et al. (1999) Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab 84 1582-1589.
187. A Starke, C Saddig, B Kirch, et al. (2006) Islet hyperplasia in adults: challenge to preoperatively diagnose non-insulinoma pancreatogenic hypoglycemia syndrome. World J Surg 30 670-679.
188. GB Thompson, FJ Service, JC Andrews, et al. (2000) Noninsulinoma pancreatogenous hypoglycemia syndrome: an update in 10 surgically treated patients. Surgery 128 937-944. discussion 944-945
189. JG Won, HS Tseng, AH Yang, et al. (2006) Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS). Clin Endocrinol (Oxf) 65 566-578.
190. GJ Service, GB Thompson, FJ Service, et al. (2005) Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353 249-254.
191. ME Patti, G McMahon, EC Mun, et al. (2005) Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48 2236-2240.
192. A Goldfine, E Mun and M Patti (2006) Hyperinsulinemic hypoglycemia following gastric bypass surgery for obesity. Cur Opin Endocrinol Diabetes 13 419-424.
193. AB Goldfine, EC Mun, E Devine, et al. (2007) Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 92 4678-4685.
194. JJ Meier, AE Butler, R Galasso, et al. (2006) Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diabetes Care 29 1554-1559.
195. A Vella and FJ Service (2007) Incretin hypersecretion in post-gastric bypass hypoglycemia: primary problem or red herring? J Clin Endocrinol Metab 92 4563-4565.
196. J Vidal, J Nicolau, F Romero, et al. (2008) Long-term effects of roux-en-Y gastric bypass surgery on plasma GLP-1 and islet function in morbidly obese subjects. J Clin Endocrinol Metab 94 884-891.
197. Y Hirata, H Ishizu, N Ouchi, et al. (1970) Insulin autoimmunity in a case with spontaneous hypoglycemia. J Jap Diabetes Soc 13 312-320.
198. A Basu, FJ Service, L Yu, et al. (2005) Insulin autoimmunity and hypoglycemia in seven white patients. Endocr Pract 11 97-103.
199. DJ Halsall, M Mangi, M Soos, et al. (2007) Hypoglycemia due to an insulin binding antibody in a patient with an IgA-kappa myeloma. J Clin Endocrinol Metab 92 2013-2016.
200. K Højlund, T Hansen, M Lajer, et al. (2004) A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene. Diabetes 53 1592-1598.
201. T Meissner, B Friedmann, JG Okun, et al. (2005) Massive insulin secretion in response to anaerobic exercise in exercise-induced hyperinsulinism. Horm Metab Res 37 690-694.
202. E Arioglu, A Andewelt, C Diabo, et al. (2002) Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective. Medicine (Baltimore) 81 87-100.
203. MJ Seckl, PJ Mulholland, AE Bishop, et al. (1999) Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix. N Engl J Med 341 733-736.
204. RA Rizza, MW Haymond, CA Verdonk, et al. (1981) Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin. Diabetes 30 377-381.
205. FJ Service and N Natt (2000) The prolonged fast. J Clin Endocrinol Metab 85 3973-3974.
206. D Vezzosi, A Bennet, J Fauvel, et al. (2007) Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. Eur J Endocrinol 157 75-83.
207. TC Noone, J Hosey, Z Firat, et al. (2005) Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metab 19 195-211.
208. AB Grossman and RH Reznek (2005) Commentary: imaging of islet-cell tumours. Best Pract Res Clin Endocrinol Metab 19 241-243.
209. I Virgolini, T Traub-Weidinger and C Decristoforo (2005) Nuclear medicine in the detection and management of pancreatic islet-cell tumours. Best Pract Res Clin Endocrinol Metab 19 213-227.
210. B Kumbasar, IR Kamel, A Tekes, et al. (2004) Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS. Abdom Imaging 29 696-702.
211. A Fritscher-Ravens (2004) Endoscopic ultrasound and neuroendocrine tumours of the pancreas. JOP 5 273-281.
212. S Kauhanen, M Seppänen, H Minn, et al. (2007) Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients. J Clin Endocrinol Metab 92 1237-1244.
213. CK Brown, DL Bartlett, JL Doppman, et al. (1997) Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas. Surgery 122 1189-1193. discussion 1193-1194
214. JL Doppman, DL Miller, R Chang, et al. (1991) Insulinomas: localization with selective intraarterial injection of calcium. Radiology 178 237-241.
215. P Wiesli, M Brändle, C Schmid, et al. (2004) Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinemic hypoglycemia: potential and limitations. J Vasc Interv Radiol 15 1251-1256.
216. JE Jackson (2005) Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 19 229-239.
217. BH Dekelbab and MA Sperling (2006) Hypoglycemia in newborns and infants. Adv Pediatr 53 5-22.
218. FM Hoe (2008) Hypoglycemia in infants and children. Adv Pediatr 55 367-384.
219. PJ Rozance and WW Hay (2006) Hypoglycemia in newborn infants: Features associated with adverse outcomes. Biol Neonate 90 74-86.
220. JD Losek (2000) Hypoglycemia and the ABC'S (sugar) of pediatric resuscitation. Ann Emerg Med 35 43-46.
221. MW Haymond, IE Karl and AS Pagliara (1974) Increased gluconeogenic substrates in the small-for-gestational-age infant. N Engl J Med 291 322-328.
222. MW Haymond, IE Karl and AS Pagliara (1974) Ketotic hypoglycemia: an amino acid substrate limited disorder. J Clin Endocrinol Metab 38 521-530.
223. AA Palladino, MJ Bennett and CA Stanley (2008) Hyperinsulinism in infancy and childhood: when an insulin level is not always enough. Clin Chem 54 256-263.
224. SE Pinney, C MacMullen, S Becker, et al. (2008) Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. J Clin Invest 118 2877-2886.
225. P de Lonlay, A Simon-Carre, MJ Ribeiro, et al. (2006) Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion. J Clin Endocrinol Metab 91 933-940.
226. MJ Ribeiro, N Boddaert, C Bellanné-Chantelot, et al. (2007) The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children. Eur J Nucl Med Mol Imaging 34 2120-2128.
227. OT Hardy, M Hernandez-Pampaloni, JR Saffer, et al. (2007) Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. J Clin Endocrinol Metab 92 4706-4711.
228. J Yang Chou and BC Mansfield (1999) Molecular genetics of type 1 glycogen storage diseases. Trends Endocrinol Metab 10 104-113.
229. D Weghuber, M Mandl, M Krssák, et al. (2007) Characterization of hepatic and brain metabolism in young adults with glycogen storage disease type 1: a magnetic resonance spectroscopy study. Am J Physiol Endocrinol Metab 293 E1378-E1384.
230. M Muraca, G Gerunda, D Neri, et al. (2002) Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 359 317-318.
231. GK Brown (2000) Glucose transporters: structure, function and consequences of deficiency. J Inherit Metab Dis 23 237-246.
232. CR Roe, PM Coates (1995) Mitochondrial fatty acid oxidation disorders. CR Scriver, AL Beaudet, WS Sly, et al., (Eds) The Metabolic and Molecular Bases of Inherited Disease 7th ed New York, NY: McGraw-Hill 1501-1533.
233. CA Stanley (1998) Dissecting the spectrum of fatty acid oxidation disorders. J Pediatr 132 384-386.
234. J Nezu, I Tamai, A Oku, et al. (1999) Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21 91-94.
235. C Vianey-Saban, N Guffon, F Delolne, et al. (1997) Diagnosis of inborn errors of metabolism by acylcarnitine profiling in blood using tandem mass spectrometry. J Inherit Metab Dis 20 411-414.
236. PF Bougnères, JM Saudubray, C Marsac, et al. (1981) Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. J Pediatr 98 742-746.